The development of potentially reversible physiologic derangement involving two or more organ systems not involved in the disorder that resulted in intensive care unit (ICU) admission, and arising in ...
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
APT Pharmaceuticals, Inc.
Other
Astellas Pharma Global Development, Inc.
Other
Astellas Pharma US, Inc.
Other
Biotransplant, Inc.
Other
Bristol-Myers Squibb Company
Other
Conatus Pharmaceuticals Inc.
Other
Regenerex LLC
Other
Research Triangle Pharmaceuticals
Other
Veloxis Pharmaceuticals, Inc
Other